Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients

Notwithstanding some improvement in the earlier detection of patients with lung cancer, most of them still present with a late-stage disease at the time of diagnosis. Next to the most frequently utilized factors affecting the prognosis of lung cancer patients (stage, performance, and age), the recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischhacker, Michael, Arslan, Erkan, Reinicke, Dana, Eisenmann, Stefan, Theil, Gerit, Kollmeier, Jens, Schäper, Christoph, Grah, Christian, Klawonn, Frank, Holdenrieder, Stefan, Schmidt, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340633/
https://www.ncbi.nlm.nih.gov/pubmed/37443525
http://dx.doi.org/10.3390/diagnostics13132131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340633/
https://www.ncbi.nlm.nih.gov/pubmed/37443525
http://dx.doi.org/10.3390/diagnostics13132131

Ejemplares similares